Pembrolizumab (Keytruda®) Approved as First-Line Option for Lung Cancer October 25, 2016December 14, 2022 Arthur N. Brodsky, PhD
AACR17 Update: Checkpoint Immunotherapy Trials in Melanoma and Lung Cancer April 6, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA approves Keytruda combo for first-line lung cancer treatment May 12, 2017December 14, 2022 Arthur N. Brodsky, PhD
Advances in Personalized Approaches Against Cancer December 22, 2017December 14, 2022 Arthur N. Brodsky, PhD
Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD